ME-344, a novel mitochondrial oxygenase inhibitor: Results from a first-in-human Phase I study.

被引：6

作者：

Bendell, Johanna C. ^{[1
]}

Patel, Manish ^{[2
]}

Infante, Jeffrey R. ^{[1
]}

Kurkjian, Carla ^{[3
]}

Jones, Suzanne ^{[4
]}

Pant, Shubham ^{[3
]}

Burris, Howard A. ^{[1
]}

Hainsworth, John D. ^{[1
]}

Moreno, Ofir ^{[5
]}

Moore, Kathleen ^{[3
]}

机构：

[1] Sarah Cannon Res Inst Tennessee Oncol PLLC, Nashville, TN USA

[2] Florida Canc Specialists SCRI, Ft Myers, FL USA

[3] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] MEI Pharma Inc, San Diego, CA USA

来源：

关键词：

D O I：

10.1158/1535-7163.TARG-13-A17

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

A17

引用

页数：2